Glutamate transporters: animal models to neurologic disease

被引:285
作者
Maragakis, NJ [1 ]
Rothstein, JD [1 ]
机构
[1] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
关键词
glutamate; central nervous system; neurologic diseases;
D O I
10.1016/j.nbd.2003.12.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:461 / 473
页数:13
相关论文
共 97 条
[1]   Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance [J].
Arriza, JL ;
Eliasof, S ;
Kavanaugh, MP ;
Amara, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :4155-4160
[2]   Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - An in situ hybridization study [J].
Arzberger, T ;
Krampfl, K ;
Leimgruber, S ;
Weindl, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (04) :440-454
[3]  
BarPeled O, 1997, J NEUROCHEM, V69, P2571
[4]  
Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO
[5]  
2-C
[6]   Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation [J].
Behrens, P. F. ;
Franz, P. ;
Woodman, B. ;
Lindenberg, K. S. ;
Landwehrmeyer, G. B. .
BRAIN, 2002, 125 :1908-1922
[7]  
Bellocchio EE, 1998, J NEUROSCI, V18, P8648
[8]   ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions [J].
Bruijn, LI ;
Becher, MW ;
Lee, MK ;
Anderson, KL ;
Jenkins, NA ;
Copeland, NG ;
Sisodia, SS ;
Rothstein, JD ;
Borchelt, DR ;
Price, DL ;
Cleveland, DW .
NEURON, 1997, 18 (02) :327-338
[9]   Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain [J].
Chen, WZ ;
Aoki, C ;
Mahadomrongkul, V ;
Gruber, CE ;
Wang, GJ ;
Blitzblau, R ;
Irwin, N ;
Rosenberg, PA .
JOURNAL OF NEUROSCIENCE, 2002, 22 (06) :2142-2152
[10]  
CHOI DW, 1987, J NEUROSCI, V7, P357